Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

March 27 2023 - Novartis' Kisqali cuts recurrence risk in early-stage breast cancer

Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
Novo's high-dose Rybelsus win tees up regulatory filings
BioNTech's COVID-19 vaccine revenue forecasts lower than expected
BrainStorm secures FDA adcomm for ALS therapy NurOwn
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings

Sanofi, Regeneron's Dupixent could hit $20B in peak sales with COPD expansion: analyst

Fierce Pharma

Sunday, March 26, 2023 - 11:30pm

tags:

Sanofi, Regeneron, Dupixent, COPD

The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win

Investors Business Daily

Sunday, March 26, 2023 - 11:28pm

tags:

Novo Nordisk, Ozempic, diabetes, obesity

GSK plays defense after California judge approves plaintiff's expert testimony in high-stakes Zantac trial

Fierce Pharma

Sunday, March 26, 2023 - 11:21pm

tags:

GSK, Zantac, California, legal

This Cancer Drug Candidate Could Be a Hit for Pfizer

Motley Fool

Sunday, March 26, 2023 - 11:19pm

tags:

Pfizer, elranatamab, Multiple Myeloma

FDA approves Pharming drug for ultra-rare immunodeficiency disease

Endpoints

Sunday, March 26, 2023 - 11:16pm

tags:

FDA, Pharming, Novartis, leniolisib, APDS

FDA outlines plan for digital health technologies for clinical trials

RAPS.org

Sunday, March 26, 2023 - 11:15pm

tags:

FDA, regulatory, clinical trials, digital health

Pharma’s TV buys show it’s loath to change channels

Medical Marketing and Media

Sunday, March 26, 2023 - 11:14pm

tags:

pharma advertising, television ads

Valneva, Pfizer delay end date of Lyme disease vaccine phase 3 trial to 2025

Seeking Alpha

Sunday, March 26, 2023 - 11:12pm

tags:

Pfizer, Valneva, clinical trials, vaccines, Lyme disease, VLA15

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

CP Wire

Sunday, March 26, 2023 - 3:44pm

tags:

PTC Therapeutics, Novartis, Zolgensma, SMA, Novo Nordisk, Ozempic, obesity, diabetes, Baxter, M&A, Celltrio, Thermo Fisher, Pfizer, Astellas, Xtandi, NIH

AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus

BioSpace

Friday, March 24, 2023 - 11:50am

tags:

AbbVie, Skyrizi, ulcerative colitis, lupus, Rinvoq, clinical trials

PTC Therapeutics CEO Stuart Peltz to retire after 25 years

NASDAQ.com

Friday, March 24, 2023 - 11:44am

tags:

Pharma CEOs, PTC Therapeutics, Stuart Peltz

Brii Bio shelves once-promising COVID antibody combo that stood up to variants

Fierce Pharma

Friday, March 24, 2023 - 11:40am

tags:

Brii Biosciences, COVID-19, BRII-196/198, China, FDA

SPACs back from brink with NK cell therapy biotech's plans for blank-check merger

Fierce Biotech

Friday, March 24, 2023 - 10:12am

tags:

SPACs, natural killer cell therapy, NKGen, cell therapy

Has Penumbra Caught Lightning in a Bottle?

Medical Devices and Diagnostics Industry

Friday, March 24, 2023 - 10:10am

tags:

Penumbra, Medtech, Lightning Flash, Lightning Bolt, thrombectomy

Biotech startups face ‘Series A cliff’ as venture capital stays cautious

BioPharma Dive

Friday, March 24, 2023 - 10:08am

tags:

funding, venture capital, Series A, Series B

Incyte hit by CRL on extended-release JAK tablets, muddying plans for Jakafi franchise expansion

Endpoints

Friday, March 24, 2023 - 10:05am

tags:

Incyte, FDA, ruxolitinib, CRL

Hard pressed for cash, Cyclerion looks for help funding rare disease drug

Endpoints

Friday, March 24, 2023 - 10:04am

tags:

Cyclerion, clinical trials, MELAS, zagociguat

Relmada, reeling from 2 late-phase flops, plots comeback for depression drug

Fierce Biotech

Friday, March 24, 2023 - 10:02am

tags:

Relmada Therapeutics, clinical trials, depression, REL-1017

Lazertinib and Tagrisso go head to head

EP Vantage

Friday, March 24, 2023 - 10:01am

tags:

AstraZeneca, lazertinib, Tagrisso, JNJ, lung cancer

Future of abortion pills hangs in the balance as court hears case against mifepristone

Medical Marketing and Media

Friday, March 24, 2023 - 10:00am

tags:

abortion pills, FDA, mifepristone

Pages

Latest CP Wire Articles

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

Klick Health launches new healthcare venture studio

Medtech earnings reports: insights from major players' Q4 results

Key compliance issues for medtech firms transitioning to data-enabled solutions

Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

First-of-its-kind Whole Lung Simulator is Helping Michigan Researchers Predict New Treatments and Vaccines for TB – A Reemerging Global Health Threat

Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug

Korean firm LG Chem buying AVEO Oncology for $566M

Latest Pharmagather Articles

Behind the GoodRx-Express Scripts Partnership: How PBMs Profit from Discount Cards in Pharmacy Benefits (rerun)

Drug Channels

Winning the Race for Patient Access: Identifying Copay Accumulator Impact

Drug Channels

Gene Drives Are Coming

In the Pipeline

Organizing Our Thoughts About Cells - Finally

In the Pipeline

Drug Channels News Roundup, March 2023: My $0.02 on Insulin Price Cuts, AbbVie vs. AFPs, Optum Expands, ASAP340B, and Hooray for Pharmacists

Drug Channels

The Right Assay With the Right Cells

In the Pipeline

Informa Connect’s Annual Life Sciences Commercial Contracts & Chargebacks Congress

Drug Channels

Peptide-Encoded Screening Libraries

In the Pipeline

It's Not All Bad News: Data Shows There's a Collaborative Future for 340B

Drug Channels